Price Alert

Novartis AG (NVS)

NYSE: NVS · Real-Time Price · USD

123.70

1.47 (1.20%)

At close: Sep 26, 2025, 3:59 PM

123.46

-0.19%

Pre-market: Sep 29, 2025, 09:28 AM EDT

Novartis Statistics

Share Statistics

Novartis has 1.95B shares outstanding. The number of shares has increased by 0.95% in one year.

Shares Outstanding	1.95B
Shares Change (YoY)	0.95%
Shares Change (QoQ)	0%
Owned by Institutions (%)	7.07%
Shares Floating	1.84B
Failed to Deliver (FTD) Shares	2,225
FTD / Avg. Volume	0.15%

Short Selling Information

The latest short interest is 4.27M, so 0.22% of the outstanding shares have been sold short.

Short Interest	4.27M
Short % of Shares Out	0.22%
Short % of Float	0.22%
Short Ratio (days to cover)	3.57

Valuation Ratios

The PE ratio is 16.45 and the forward PE ratio is 13.2. Novartis's PEG ratio is -0.96.

PE Ratio	16.45
Forward PE	13.2
PS Ratio	3.8
Forward PS	4.3
PB Ratio	4.46
P/FCF Ratio	14.22
PEG Ratio	-0.96

Financial Ratio History

Enterprise Valuation

Novartis has an Enterprise Value (EV) of 216.17B.

EV / Sales	4.18
EV / EBITDA	10.44
EV / EBIT	12.27
EV / FCF	15.66

Financial Position

The company has a current ratio of 1.04, with a Debt / Equity ratio of 0.71.

Current Ratio	1.04
Quick Ratio	0.84
Debt / Equity	0.71
Debt / EBITDA	1.51
Debt / FCF	2.26
Interest Coverage	14.03

Financial Efficiency

Return on Equity is 27.11% and Return on Invested Capital is 15.55%.

Return on Equity	27.11%
Return on Assets	11.68%
Return on Invested Capital	15.55%
Revenue Per Employee	$681.6K
Profits Per Employee	$157.36K
Employee Count	75,883
Asset Turnover	0.51
Inventory Turnover	2.24

Taxes

Income Tax	1.7B
Effective Tax Rate	12.47%

Stock Price Statistics

The stock price has increased by 7% in the last 52 weeks. The beta is 0.56, so Novartis's price volatility has been higher than the market average.

Beta	0.56
52-Week Price Change	7%
50-Day Moving Average	122.06
200-Day Moving Average	112.53
Relative Strength Index (RSI)	49.16
Average Volume (20 Days)	1,499,457

Income Statement

In the last 12 months, Novartis had revenue of 51.72B and earned 11.94B in profits. Earnings per share was 5.92.

Revenue	51.72B
Gross Profit	38.9B
Operating Income	14.54B
Net Income	11.94B
EBITDA	20.71B
EBIT	14.65B
Earnings Per Share (EPS)	5.92

Full Income Statement

Balance Sheet

The company has 11.46B in cash and 31.26B in debt, giving a net cash position of -19.8B.

Cash & Cash Equivalents	11.46B
Total Debt	31.26B
Net Cash	-19.8B
Retained Earnings	n/a
Total Assets	104.39B
Working Capital	-5.78B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.62B and capital expenditures -3.81B, giving a free cash flow of 13.8B.

Operating Cash Flow	17.62B
Capital Expenditures	-3.81B
Free Cash Flow	13.8B
FCF Per Share	6.84

Full Cash Flow Statement

Margins

Gross margin is 75.2%, with operating and profit margins of 28.12% and 23.09%.

Gross Margin	75.2%
Operating Margin	28.12%
Pretax Margin	26.37%
Profit Margin	23.09%
EBITDA Margin	40.05%
EBIT Margin	28.12%
FCF Margin	26.69%

Dividends & Yields

NVS pays an annual dividend of $3.99, which amounts to a dividend yield of 3.68%.

Dividend Per Share	$3.99
Dividend Yield	3.68%
Dividend Growth (YoY)	5.74%
Payout Ratio	58.22%
Earnings Yield	6.08%
FCF Yield	7.03%

Dividend Details

Analyst Forecast

The average price target for NVS is $119, which is -3.8% lower than the current price. The consensus rating is "Hold".

Price Target	$119
Price Target Difference	-3.8%
Analyst Consensus	Hold
Analyst Count	4

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	$64.11
Lynch Upside	-48.17%
Graham Number	53.91
Graham Upside	-56.42%

Stock Splits

The last stock split was on Apr 9, 2019. It was a forward split with a ratio of 279:250.

Last Split Date	Apr 9, 2019
Split Type	forward
Split Ratio	279:250

Scores

Altman Z-Score	3.69
Piotroski F-Score	6